MedTrace Logo

MaxART: Early Access to ART for All in Swaziland

NCT02909218 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3485

Last updated 2018-07-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate the feasibility, acceptability, clinical outcomes, affordability, and scalability of offering early antiretroviral treatment to all HIV-positive individuals in Swaziland's government-managed health system.

Conditions

Interventions

OTHER

Early Access to ART for All

All HIV-positive individuals will be initiated on Swaziland's recommended first-line ART regimen, unless contraindicated when recommended alternate regimens will be used per national guidelines.

Sponsors & Collaborators

  • Ministry of Health, Swaziland

    collaborator OTHER_GOV

  • STOP AIDS NOW! (SAN!)

    collaborator UNKNOWN

  • Swaziland National Network of People Living with HIV/AIDS (SWANNEPHA)

    collaborator UNKNOWN

  • Southern African AIDS Information Dissemination Service (SAfAIDS)

    collaborator UNKNOWN

  • Southern African Centre for Epidemiological Modelling and Analyses (SACEMA)

    collaborator UNKNOWN

  • University of Amsterdam

    collaborator OTHER

  • Harvard School of Public Health (HSPH)

    collaborator OTHER

  • Clinton Health Access Initiative Inc.

    lead OTHER

Principal Investigators

  • Velephi Okello, MD · Ministry of Health, Swaziland

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-01
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • Eswatini

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02909218 on ClinicalTrials.gov